Contribution: Industrial Research Assistance Program – Contributions to Firms
Pharma In Silica inc.
$34,690.00
ARP - Formulation of a therapeutic vector against tumors
FY 2020-21 · 2021-01-04
Summary
Improvement of a silica-based therapeutic vector to increase the retention of the active within the nanovector and prevent premature release during all stages of manufacturing.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Quebec|Québec, Quebec, Canada
Recipient Type
For-profit organization
Business Number
743257313
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2021-03-31
Agreement Number
963215
Agreement Start Date
2021-01-04
Agreement Title
ARP - Formulation of a therapeutic vector against tumors
Agreement Title (French)
PRA - Formulation d’un vecteur thérapeutique contre les tumeurs.
Agreement Type
Contribution
Agreement Value
$34,690.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Improvement of a silica-based therapeutic vector to increase the retention of the active within the nanovector and prevent premature release during all stages of manufacturing.
Description (French)
Amélioration d'un vecteur thérapeutique à base de silice pour accroître la rétention de l'actif à l'intérieur du nanovecteur et empêcher un relargage prématuré durant toutes les étapes de la fabrication.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Québec
Federal Riding (French)
Québec
Federal Riding Number
24059
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
743257313
Recipient City
Quebec|Québec
Recipient Country
CA
Recipient Legal Name
Pharma In Silica inc.
Recipient Operating Name
Pharma in silica
Recipient Postal Code
G1P 4S6
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2020-2021-Q4-963215
